cancer cell growth inhibit
Reading File
Reading File
Finding Sources
Finding Sources
Searching PubMed
"neoplasms"[MeSH Terms] AND "cell proliferation"[MeSH Terms]
Let me read the key Robbins sections.
Reading File
Reading File
"Cancer cell growth inhibit" could mean how the body naturally restrains cancer growth or how drugs inhibit it, so I've covered both briefly. Tell me if you meant one of them, or a specific cancer, drug or pathway.
1. Natural growth inhibition: tumor suppressors
Most tumor suppressor gene products are negative regulators of proliferation. Losing them removes the brakes on growth, and "insensitivity to growth inhibition" is a hallmark of cancer. These proteins act as transcription factors, cell cycle inhibitors, signal transducers, surface receptors, and regulators of the DNA damage response. - Robbins, Cotran & Kumar Pathologic Basis of Disease, "Insensitivity to Growth Inhibition: Tumor Suppressor Genes"
RB (the sensor of external signals)
- RB was the first tumor suppressor discovered, through familial retinoblastoma.
- Knudson's "two-hit" hypothesis says both alleles must be lost for the tumor to form.
- RB blocks the G1 to S transition. Cyclin D/CDK4/6 phosphorylation inactivates RB, and CDK inhibitors (p16/INK4a, p21) keep it active.
p53 (the monitor of internal stress, "guardian of the genome")
- TP53 is the most commonly mutated gene in human cancer.
- p53 is a transcription factor that blocks neoplastic transformation in three ways: temporary cell cycle arrest (quiescence), permanent arrest (senescence), and apoptosis. - Robbins & Kumar Basic Pathology, "TP53: Guardian of the Genome"
- In healthy cells p53 has a half-life of about 20 minutes because MDM2 targets it for destruction.
- DNA damage activates sensor kinases such as ATM. These release p53 from MDM2, so it stabilizes and drives transcription of target genes. One target is p21, a CDK inhibitor that causes G1 arrest. - Berek & Novak's Gynecology, "Tumor Suppressor Genes"
- If the damage can't be repaired, p53 sends the cell into senescence or apoptosis.
- Oncogene activation in a cell with intact tumor suppressors leads to quiescence or oncogene-induced senescence, not runaway growth.
Other tumor suppressors: APC, PTEN, NF1, TGF-β signaling components, and others. They are covered in Robbins, "Other Tumor Suppressor Genes".
2. Therapeutic growth inhibition
This section comes from my general knowledge, not from the library passages above.
| Strategy | Examples | Target |
|---|---|---|
| Cytotoxic chemotherapy | Antimetabolites, alkylators, taxanes, topoisomerase inhibitors | DNA synthesis, DNA integrity, mitosis |
| Cell cycle inhibitors | Palbociclib, ribociclib, abemaciclib | CDK4/6, which keeps RB active and arrests G1 |
| Growth factor receptor and kinase inhibitors | Imatinib, EGFR TKIs (e.g. osimertinib), trastuzumab, BRAF/MEK inhibitors | Oncogenic signaling (BCR-ABL, EGFR, HER2, BRAF) |
| Hormonal therapy | Tamoxifen, aromatase inhibitors, androgen deprivation | Estrogen or androgen signaling |
| Pro-apoptotic agents | Venetoclax | BCL-2 |
| Anti-angiogenic agents | Bevacizumab | VEGF |
| mTOR/PI3K inhibitors | Everolimus | Growth and metabolism signaling |
| Immunotherapy | PD-1/PD-L1 and CTLA-4 inhibitors | T-cell-mediated killing |
Therapeutic strategies for restoring p53 function (for example MDM2 inhibitors) are an active area of research.
3. Recent evidence check
A PubMed search for systematic reviews and meta-analyses from the last 2 years on neoplasms and cell proliferation found nothing that contradicts the textbook mechanisms above. The results were narrow topic reviews, such as PMID 42859938 on necroptosis in cervical cancer and PMID 39195765 on botulinum neurotoxin effects on neoplastic cells.
Which of these would help most?
- A specific cancer
- A specific drug class
- Lab methods such as MTT assays and in vitro growth inhibition testing
- Natural compounds that inhibit tumor growth
This is a shared conversation. Sign in to Orris to start your own chat.